论文部分内容阅读
目的:观察黄芪生脉饮联合小剂量多巴胺治疗老年性慢性心力衰竭的临床疗效。方法:将我院心内科收治符合纳入标准的68例慢性心力衰竭老年患者作为观察对象,随机分为治疗组和对照组,每组均34例。对照组予西医及常规小剂量多巴胺治疗;治疗组在对照组治疗基础上联合黄芪生脉饮治疗,连续治疗4周后比较两组患者临床疗效、心功能改善情况(LVDs、LVDd、LVEF)及心功能分级情况。结果:疗程结束后,治疗组临床总有效率(88.2%)明显高于对照组(79.4%),两组比较,差异有统计学意义(P<0.05);两组心功能相关指标LVDs、LVDd、LVEF较治疗前均有改善,治疗组改善更显著,且治疗组心功能分级改善情况与对照组比较,差异有统计学意义(P<0.05)。结论:黄芪生脉饮联合小剂量多巴胺治疗老年性慢性心力衰竭患者临床疗效肯定,可有效改善患者心功能指标及心功能分级。
Objective: To observe the curative effect of Huangqi Shengmai Decoction combined with small dose of dopamine on senile chronic heart failure. Methods: A total of 68 elderly patients with chronic heart failure who met the inclusion criteria were randomly divided into treatment group and control group, 34 cases in each group. The control group was treated with Western medicine and conventional low-dose dopamine. The treatment group was treated with Huangqi Shengmai Yin based on the control group. After 4 weeks of continuous treatment, the clinical efficacy, LVDs, LVDF and LVEF were compared between the two groups Heart function grading situation. Results: At the end of treatment, the total effective rate (88.2%) in the treatment group was significantly higher than that in the control group (79.4%). There was significant difference between the two groups (P <0.05). The LVDs and LVDd , LVEF improved than before treatment, the treatment group improved more significantly, and the improvement of cardiac function in treatment group compared with the control group, the difference was statistically significant (P <0.05). Conclusion: Astragalus Sheng Mai Yin combined with low-dose dopamine treatment of elderly patients with chronic heart failure positive clinical efficacy, can effectively improve the patient’s cardiac function and cardiac function classification.